Athersys plans reverse stock split by Monday’s market opening


In July, shareholders approved a reverse stock split to bring Athersys into compliance with Nasdaq’s minimum bid price requirement.

Previous What Pitt BioForge and ElevateBio will mean for the biotech industry — and Hazelwood
Next Fremont migraine patch developer Zosano sold in bankruptcy court for $1M